Intrinsic Value of S&P & Nasdaq Contact Us

Omega Healthcare Investors, Inc. OHI NYSE

NYSE • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
71/100
3/7 Pass
SharesGrow Intrinsic Value
$41.95
-7.9%
Analyst Price Target
$49.14
+7.9%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Omega Healthcare Investors, Inc. (OHI) has shown strong revenue growth over the past 3 years, expanding from $878M to $1.2B (average +10.9%/yr). Net income reached $590M, reflecting exceptional earnings expansion at +23.2%/yr on average. The net profit margin is 49.3%, which is exceptional. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 44.5% (moderate), with a -53.6pp trend over the period. With a $13B market cap and MOAT composite score of 58/100, the company has a moderate competitive position.

Criteria proven by this page:

  • GROWTH (90/100, Pass) — proving strong growth momentum
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 34-year history, the company was profitable in 31 of 34 years — an excellent long-term track record
  • INCOME (100/100, Pass) — proves strong profitability and pricing power
  • MOAT (58/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 71/100 with 3/7 criteria passed.

71/100
SG Score
View full scorecard →
~
VALUE
40/100
Price-to-Earnings & upside
→ IV page
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $1.94
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
58/100
Score: 58/100
GM 44.5% (-53.6pp)
Proven by this page
GROWTH
90/100
Rev +10.9%/yr
NI +23.2%/yr
Proven by this page
INCOME
100/100
Margin 49.3%
$1.2B
Proven by this page
Omega Healthcare Investors, Inc. Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $1.19B$1.2B$1.05B$949.74M$878.24M
Gross Profit $1.01B$533.17M$1.04B$890.16M$861.28M
Gross Margin 84.9%44.5%98.6%93.7%98.1%
Operating Income $746.54M$749.44M$659.66M$761.27M$390.28M
Net Income $590.07M$590.11M$406.33M$242.18M$426.93M
Net Margin 49.5%49.3%38.6%25.5%48.6%
EPS (Diluted) $1.93$1.94$1.55$1.00$1.75
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message